BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5316428)

  • 1. [Current aspects of enzyme-inhibitory therapy].
    Stoimenov G; Doĭchinov Al
    Akush Ginekol (Sofiia); 1971; 10(1):86-7. PubMed ID: 5316428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trasylol in the shock therapy. Its effects and their interpretation].
    Haberland GL; Koslowski L; Matis P
    Med Welt; 1972 Aug; 23(31):1049-56. PubMed ID: 4539608
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reactive fibrinolysis during heparin therapy in hemorrhagic-traumatic-and septic shock].
    Popov-Cenić S; Dohmen M; Baymann E
    Med Welt; 1972 Feb; 23(7):221-4. PubMed ID: 5062328
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacologic approach to the treatment of shock. I. Defining traumatic, septic, and cardiogenic shock.
    Lillehei RC; Dietzman RH; Motsay GJ; Schultz LS; Romero LH; Beckman CB
    Geriatrics; 1972 Jul; 27(7):73-83. PubMed ID: 5039885
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium antagonists in shock--a minireview of the evidence.
    Parratt JR
    Prog Clin Biol Res; 1989; 308():1065-74. PubMed ID: 2675039
    [No Abstract]   [Full Text] [Related]  

  • 6. Aprotinin therapy in septic shock.
    Putterman C
    Acta Chir Scand; 1989; 155(6-7):367. PubMed ID: 2479207
    [No Abstract]   [Full Text] [Related]  

  • 7. [Administration of digitalis glycosides in shock].
    Ciesielski L; Bilski D; Rylski J
    Pol Przegl Chir; 1969 Aug; 41(8):1003-7. PubMed ID: 5824757
    [No Abstract]   [Full Text] [Related]  

  • 8. [The protease inhibitor aprotinin in the therapy of septic shock].
    Putterman C; Bshouty Z; Bursztein S
    Harefuah; 1986 Dec; 111(12):411-4. PubMed ID: 2435623
    [No Abstract]   [Full Text] [Related]  

  • 9. [Field study on the therapeutic value of trasylol in traumatic shock].
    Schneider B; Schnells G; Trentz O; Tscherne H
    Chirurg; 1976 Apr; 47(4):185-8. PubMed ID: 1085692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of combined use of aprotinin and corticosteroid in traumatic shock rats (author's transl)].
    Kugimiya H; Suemori I
    Masui; 1978 May; 27(5):484-9. PubMed ID: 307073
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of glucagon by continuous perfusion in the treatment of shock states].
    Bernard S; Duchesne G; Herman B
    Presse Med (1893); 1971 Feb; 79(7):267-70. PubMed ID: 5576150
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of ATP and a proteolytic enzyme inhibitor in irreversible shock.
    Massion WH; Erdos EG
    J Okla State Med Assoc; 1966 Aug; 59(8):467-71. PubMed ID: 5296339
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of the proteinase inhibitor (aprotinin) on the course of experimental burn shock].
    Rybák M; Petz R; Jańecek J; Petáková M
    Cas Lek Cesk; 1976 Sep; 115(35):1067-71. PubMed ID: 1086136
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined therapy of septic shock using steroids and a proteinase inhibitor].
    Ramirez Acosta JA; Sabido RC; Diaz Miranda J
    Med Welt; 1975 Oct; 26(41):1886-90. PubMed ID: 1081637
    [No Abstract]   [Full Text] [Related]  

  • 15. [Remarks on the clinical use of dextran 40 000].
    Manicki J
    Pol Przegl Chir; 1968 Nov; 40(11):1355-62. PubMed ID: 4882817
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of a field study on the therapeutic value of aprotinin in traumatic shock (author's transl)].
    Schneider B
    Arzneimittelforschung; 1976; 26(8):1606-10. PubMed ID: 795437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Practical notions in the treatment of shock].
    Hanquet M
    Rev Med Liege; 1967 Mar; 22(6):168-71. PubMed ID: 4387281
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of hydrocortisone and aprotinin in endotoxin shock (author's transl)].
    Ebata T; Osanai H; Kobayashi K; Totsuka M; Hayasaka H
    Masui; 1978 May; 27(5):463-6. PubMed ID: 307072
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trasylol R on the status of experimental shock (preliminary results)].
    Back N; Wilkens H; Munson AE; Steger R
    Rev Bras Med; 1968 Jun; 25(6):410-5. PubMed ID: 5304846
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current concepts in physiopathology and the management of "shock"].
    De Roni EA; Navia JA; Montrul M; Invierno J; Rossi C; Esandi F; Echeverria H
    Prensa Med Argent; 1968 May; 55(14):628-38. PubMed ID: 5720923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.